EXCLUSIVE: THE White House expects to announce an expansion of drugmakers offering discounts on TrumpRx.gov, FOX Business has learned.
Starting today, Amgen and GSK will be added to the list of prescription drug manufacturers offering discounts on the government’s website. That makes a total of 54 prescription drugs from six pharmaceutical companies that signed on to the most favored nation tariff under pressure from the president. Donald Trump and the threat of tariffs.
Amgen will offer medications on the website at an 80% discount off the retail price. Amjevita has an initial price of $1,484, but will be available on TrumpRx.gov for $299. The drug treats rheumatoid arthritis, psoriasis and ulcerative colitis.
FOX NEWS POLL: VOTERS SOUND THE ALARM ON HEALTH CARE COSTS
President Donald Trump speaks as Centers for Medicare and Medicaid Services Administrator Mehmet Oz speaks during a drug pricing event at the South Court Auditorium on the White House campus February 5, 2026, in Washington, DC. (Nathan Howard/Getty Images)
The company plans to list Aimovig and Repatha at discounts of 62%.
GSK will discount Incruse at 55% of the retail price. The drug treats COPD and will cost $159.
GSK also plans to offer Arnuity, Relenza and Anoro at discounts ranging from 10% to 51%.
Teleprinter Security Last Change Change % AMGN AMGEN INC. 366.21 -1.58 -0.43% GSK GSK PLC 53.39 -0.89 -1.64% “GSK and Amgen are partnering with TrumpRx.gov to bring prescription drugs directly to consumers at Most Favored Nations prices, marking another milestone in President Trump’s affordability campaign,” White House spokesperson Kush Desai told FOX Business.
“TrumpRx.gov is just the beginning, however, as Americans are poised to (receive) even deeper drug price discounts, lower insurance premiums and more transparency when Congress passes President Trump’s big health plan.”
Amgen will offer medications on the website at an 80% discount off the retail price. (George Frey/Bloomberg via Getty Images)
The Pharmaceutical Research and Manufacturers of America represents major pharmaceutical companies.
CEO Stephen Ubl believes “Imposed by the government Most Favored Nation policies would harm U.S. competitiveness without doing anything to address insurance practices that deny care and increase costs for patients.
HOUSE GOP SEEKS EXIT FOR HIGH HEALTH INSURANCE COSTS FOR MILLIONS OF AMERICANS
“These policies would siphon billions of dollars from U.S. R&D, slow the pace of cures, and increase reliance on China for future innovation.”
GSK will discount Incruse at 55% of the retail price. (Jeffrey Greenberg/Universal Images Group via Getty Images)
The White House continues its announcements on TrumpRx.gov as Americans look for ways to reduce medical costs.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Under the Biden administration, Data from the Bureau of Labor Statistics shows that prescription drug costs increased 10.4% from January 2021 to January 2025. Under the Trump administration, prescription drug prices increased 0.2% between January 2025 and the latest data from February 2026.